Green Bioactives receives £200k Grant Funding from Innovate UK
Edinburgh, Scotland, 1 October 2020 – Green Bioactives Ltd (‘GBL’), a company pioneering the discovery, development and sustainable production of high-value plant natural products, announces its launch following a £200,000 grant from Innovate UK. The grant will allow Green Bioactives to accelerate the development of its plant cell biomanufacturing platform and supply plant bioactive ingredients in a sustainable way.
The funding was awarded following a competitive process, which included a presentation to a panel of industry experts at the Institute of Directors, Pall Mall, London.
Green Bioactives has explored the global plant natural products market and identified an urgent requirement for robust and sustainable sources of plant bioactive molecules across a range of industrial sectors. Its platform therefore aims to provide much improved and sustainable access to the huge, diverse, and valuable library of these bioactives.
Gary Loake, founder and CEO of Green Bioactives, said: “We’re delighted that Innovate UK has seen the strong potential in Green Bioactives’ approach. With this grant we are able to take the first steps towards realising our vision of becoming the world's leading supplier of safe, natural and sustainably-sourced plant-derived products, employing processes that help protect and improve the quality of our environment.”
About Green Bioactives
Green Bioactives ("GBL”) is a world leader in the commercial utilisation of plant vascular stem cells, which has allowed it to create a reliable and economically attractive platform for the sustainable biomanufacturing of plant biomolecules for the cosmetics, pharma, food and agricultural industries.
GBL’s platform provides much improved and sustainable access to the huge, diverse, and valuable library of bioactives generated by the world’s plant population.
GBL is working with several world leading partners to produce high value bioactives that cannot be produced sustainably or economically using other approaches. The company’s capabilities span initial isolation of the bioactive producing plant cells through to the supply of the final purified product.
GBL’s knowledge of plant vascular stem cells also provides the opportunity for the company to develop novel approaches that address the global need for sustainable, more efficient food production.
GBL was founded in 2020 and is currently based at the Roslin Innovation Centre, Edinburgh, Scotland.
David McElroy, Director
David Dible, Eleanor Perkin, Sandi Greenwood
Tel: +44 203 928 6900